Treatment options in unstable angina: a clinical update

K A Fox1, E M Antman

  • 1Department of Cardiology, University of Edinburgh, UK.

European Heart Journal
|October 28, 1998
PubMed

Insights

Low-molecular-weight heparin (LMWH) enoxaparin offers a more effective treatment for unstable coronary artery disease than unfractionated heparin. This improved efficacy, particularly with a 1.0 mg/kg dose, persists post-treatment with fewer major hemorrhages.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Unstable coronary artery disease treatment commonly uses aspirin and intravenous heparin.
  • This standard treatment has a notable failure rate due to heparin and aspirin's properties.
  • Low-molecular-weight heparins (LMWHs) present theoretical and practical advantages over unfractionated heparin.

Purpose of the Study:

  • To evaluate the efficacy and safety of enoxaparin, a specific LMWH, compared to unfractionated heparin in treating unstable coronary artery disease.
  • To assess the long-term benefits and optimal dosage of enoxaparin.

Main Methods:

  • Clinical trials were conducted to compare enoxaparin with unfractionated heparin.
  • Enoxaparin was administered subcutaneously at 1.0 mg/kg every 12 hours for 2-8 days.
  • Different dosages of enoxaparin were assessed for efficacy and bleeding risk.

Main Results:

  • Enoxaparin (1.0 mg/kg every 12h) demonstrated significantly greater effectiveness than unfractionated heparin.
  • The therapeutic benefits of enoxaparin extended beyond the treatment period.
  • A dosage of 1.0 mg/kg every 12h showed efficacy comparable to higher doses but with a substantially reduced rate of major hemorrhage.

Conclusions:

  • Enoxaparin is a more effective treatment option for unstable coronary artery disease compared to unfractionated heparin.
  • The 1.0 mg/kg every 12h dosage of enoxaparin provides optimal efficacy with an improved safety profile, specifically lower bleeding risk.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...